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http://dx.doi.org/10.1016/j.stemcr.2016.12.015SUMMARYThe lymphoid-myeloid transdifferentiation potentials of members of the C/EBP family (C/EBPa, b, d, and ε) were compared in v-Abl-
immortalized primary B cells. Conversion of B cells to macrophages was readily induced by the ectopic expression of any C/EBP, and
enhanced by endogenous C/EBPa and b activation. High transgene expression of C/EBPb or C/EBPε, but not of C/EBPa or C/EBPd,
also induced the formation of granulocytes. Granulocytes andmacrophages emerged in amutually exclusivemanner. C/EBPb-expressing
B cells produced granulocyte-macrophage progenitor (GMP)-like progenitors when subjected to selective pressure to eliminate lymphoid
cells. The GMP-like progenitors remained self-renewing and cytokine-independent, and continuously produced macrophages and gran-
ulocytes. In addition to their suitability to study myelomonocytic lineage bifurcation, lineage-switched GMP-like progenitors could
reflect the features of the lympho-myeloid lineage switch observed in leukemic progression.INTRODUCTION
Hematopoiesis is thought to begin from stem cells that
progress through consecutive precursor cell stages in a hier-
archical fashion whereby lineage commitment precludes
alternative cell differentiation. However, there has been
increasing evidence of hematopoietic plasticity and cell
lineage conversion, particularly during leukemogenesis
(Cobaleda and Busslinger, 2008; Graf, 2008; Greaves
et al., 1986; Regalo and Leutz, 2013). The transcription fac-
tors C/EBPa and C/EBPb are potent inducers of myelomo-
nocytic genes in heterologous cell types (Ness et al.,
1993), and the experimental conversion of lymphoid cells
tomyeloid cellsmodulated by bothC/EBPs has highlighted
their lympho-myeloid transdifferentiation potential (Graf
and Enver, 2009).
The C/EBP family members C/EBPa, C/EBPb, C/EBPd,
and C/EBPε are expressed in myeloid cells (Cloutier et al.,
2009; Scott et al., 1992). Loss-of-function studies in genet-
ically modified mice suggested combinatorial and partially
redundant functions of C/EBPs in myelopoiesis (Tsukada
et al., 2011). Knockout studies showed that deletion of
Cebpa has the strongest impact on myelopoiesis, resulting
in an almost complete loss of neutrophils and impaired
development of granulocyte-macrophage progenitor
(GMP) cells (Zhang et al., 1997, 2004). However, cytokines
could compensate for the lack ofCebpa by the concomitant
activation of Cebpb, and genetic replacement of Cebpawith
Cebpb in the Cebpa locus compensates for the Cebpa
requirement in hematopoiesis and liver functions (Chen
et al., 2000; Hirai et al., 2006; Jones et al., 2002). Individual
deletions of C/EBPb, d, and ε evoke milder and gene-spe-Stem
This is an open access article under the Ccific phenotypes, such as susceptibility to infections, failure
of emergency granulopoiesis, impaired cytokine produc-
tion, and partial granulocyte deficiency that is intensified
by compound C/EBP gene deletions. For example, com-
pound Cebpb/Cebpe deletion mutants display impaired
granulopoiesis, defective macrophage functions, and a dis-
rupted innate immune regulatory gene expression
network, confirming the compensatory and redundant
functions of the C/EBPs (Akagi et al., 2010; Hirai et al.,
2006; Litvak et al., 2009; Tanaka et al., 1995; Yamanaka
et al., 1997).
C/EBPa can stimulate the transdifferentiation of B and
T cells and, together with PU.1, even fibroblasts into mac-
rophages (Bussmann et al., 2009; Feng et al., 2008; Ness
et al., 1993; Xie et al., 2004). Conversion of B cells into in-
flammatory-type macrophages occurs rapidly after C/EBP
expression, with high efficiency and through a direct route
(Bussmann et al., 2009; Di Tullio et al., 2011; Xie et al.,
2004). An experimental transdifferentiation system based
on an estrogen-responsive, conditional C/EBPa protein in
the v-H-ras-transformed pre-B cell line HAFTL1 (Holmes
et al., 1986) has served as a tool to examine themechanistic
aspects of lympho-myeloid lineage conversion, including
alterations of chromatin occupancy, gene expression ki-
netics, non-coding RNA expression, and DNAmethylation
(Barneda-Zahonero et al., 2013; Di Tullio et al., 2011; Kallin
et al., 2012; Krijger et al., 2016; Rodriguez-Ubreva et al.,
2012, 2014; van Oevelen et al., 2015).
We recently found that structural alterations and post-
translational modification sites of C/EBPb may determine
the path of transdifferentiation of primary progenitor
B cells toward distinct myeloid cell fates (includingCell Reports j Vol. 8 j 1–14 j February 14, 2017 j ª 2016 The Authors. 1
C BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. C/EBPa, b, d, and ε Transdiffer-
entiate B Cells to Myeloid Cells
(A) pMSCV-based vectors containing an in-
ternal ribosomal entry site (IRES) and EGFP
(MIG) marker used for retroviral trans-
duction. Full-length open reading frames of
Cebpa, Cebpb, Cebpd, or Cebpe were inserted
upstream of the IRES element. Empty vector
(MIG) served as control.
(B) Flow cytometric analysis of GFP+-in-
fected B cells 4 days after transduction with
individual C/EBPs.
(C) Analysis of granulocyte (Ly-6G) and
macrophage (CD115) cell-surface markers in
GFP+CD11b+ transdifferentiated cells 6 days
after transduction.
(D) May-Gru¨nwald staining of GFP+-sorted B
cells 4 days after transduction. Arrows
indicate cells with typical macrophage
morphology and arrowheads mark gran-
ulocyte-like cells. Primary bone marrow (BM)
and sorted granulocytes (Gr) were used as
references (far right).
See also Figure S1.
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netic instructions beyond the inflammatory macrophage
cell fate are encoded in the C/EBP structure and could ac-
count for cell-type specification (Stoilova et al., 2013).
This observation has prompted us to compare the lineage
conversion capacity of all transactivator C/EBP family
members and to develop a lympho-myeloid transdifferen-
tiation system that is amenable to targeted mouse genetics
and cell-culture manipulation.
In this study, we generatedmurine v-Abl-immortalized B
cells from wild-type and genetically altered mice to
compare the lympho-myeloid transdifferentiation poten-
tial of the C/EBP family members C/EBPa, C/EBPb, C/
EBPd, and C/EBPε. Our data showed that C/EBPb and C/
EBPε readily induce a granulocytic fate in addition to
macrophage formation. Granulocytic conversion largely
depended on transgene dosage. In addition, efficient
transdifferentiation required endogenous Cebpa/Cebpb.
Importantly, applying selective pressure on immortalized
B cells expressing C/EBPb by depriving b-mercaptoethanol
resulted in the rapid extinction of B cells and massive
expansion of stable myeloid cells. These myeloid progeni-
tors displayed bipotential GMP-like properties and contin-2 Stem Cell Reports j Vol. 8 j 1–14 j February 14, 2017uously produced macrophages and granulocytes. This
process could suggest a link between C/EBP-induced lym-
pho-myeloid lineage switch and a B cell-derived leukemic
myelomonocytic GMP-like phenotype (Slamova et al.,
2013).RESULTS
Transdifferentiation Potential of Various C/EBP
Family Members
v-Abl-immortalized pre-B cells derived fromprimarymouse
bonemarrow cells (hereafter termed ‘‘B cells’’) were used to
assess the ability of individual C/EBP family members to
induce B-lymphoid tomyeloid transdifferentiation (Rosen-
berg et al., 1975; Shore et al., 2002). pMSCV-based retroviral
expression vectors (MIG) encoding full-length C/EBPa-,
C/EBPb-, C/EBPd-, or C/EBPε-IRES-EGFP were constructed
(Figure 1A). Transgene expression was confirmed in the
retrovirus-packaging cell line (Figure S1A). As shown in Fig-
ure 1B, eachC/EBP familymember could induce expression
of the myeloid marker CD11b (Mac-1) and caused the
transdifferentiation of B cells into CD11b+CD19dim
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tive of dendritic cells (CD11c+), macrophages (CD115+),
or granulocytes (Ly-6G+), were included to assess myeloid
subsets in the CD11b+ population (Figure S1B). While no
CD11c+ cells were found, a fraction of transdifferentiated
cells showed upregulated CD115 (MCSF-R), a macrophage
marker and C/EBP target gene. A CD11b+Ly-6G+ popu-
lation, characteristic of granulocytes, was detected with
C/EBPε expression, consistent with observations of strong
mRNA expression of C/EBPε in bone marrow-derived
granulocytes (Figures S1B and S1C). C/EBPb expression
also caused the formation of a CD11b+Ly-6G+ population
after prolonged transdifferentiation for 6 days, whereas
C/EBPa and C/EBPd expression did not (Figures 1C and
S1B). Interestingly, the expression of Ly-6G and CD115
appeared to be mutually exclusive, as no double-positive
cells could be detected, indicating a stringent mechanism
of cell-fate decision (Figure 1C). Cytospin preparations
of GFP+ cells confirmed that all C/EBPs stimulated the
formation of myeloid cells with monocyte/macrophage
features (Figure 1D). The C/EBPb- and C/EBPε-transdiffer-
entiated cell population contained small cells with
segmented or indented nuclei, strongly resembling bone
marrow-derived granulocytes and suggesting that C/EBPε
or C/EBPb may induce granulocyte/macrophage (G/M)
cell fates. Transdifferentiation into granulocytes by
C/EBPb and C/EBPε was not restricted to the v-Abl B cell
system, but also occurred in the fetal liver-derived H-ras-
transformed HAFTL1 pre-B cell line (Figure S1D) (Buss-
mann et al., 2009). These findings suggest that all the tested
C/EBP transcription factors could cause the conversion of
B cells to myeloid cells and that C/EBPb and C/EBPε could
stimulate macrophage and granulocyte transdifferentia-
tion of B cells.
Quantitative gene expression analysis was performed by
NanoString hybridization 1 day after transduction with in-
dividual C/EBPs, at the earliest emergence of GFP-positive
cells (Figures 2A and 2B; Table S1). A predefined mouse
immunology code set covering 547 probes, including key
transcription factors, was used. Genes with 2-fold altered
expression levels, compared with empty vector-transduced
B cell controls, were considered. As shown in Figures 2A
and 2B, all C/EBPs upregulated and downregulated a core
set of 22 and 12 genes, respectively. Each C/EBP family
member also displayed additional and partial overlapping
regulatory specificity. The core transdifferentiation signa-
ture of 22 upregulated genes included myeloid factors,
such as Csf1r, Csf2rb, Fcgr1, and Gfi1, and several chemo-
kine CC-family members (Figure 2C). The 12 downregu-
lated genes included lymphocyte genes, such as Il7r, Cd2,
and the Rag genes (Figure 2D). These data suggest that
C/EBPa, b, d, and ε likely suppress the B cell program and
induce lympho-myeloid conversion.Deletion of Endogenous Cebpa and Cebpb Impairs
Transdifferentiation but Has No Impact on Cell-Type
Outcome
As previously reported by Bussmann et al. (2009) and
shown in Figure S2A, activation of conditional C/EBPa-ER
induced endogenous Cebpb and Cebpd gene expression in
HAFTL1 B cells. We induced myeloid transdifferentiation
via C/EBPε expression inHAFTL1 cells and analyzed endog-
enous C/EBPa and C/EBPb protein expression. Interest-
ingly, the expression of C/EBPε also led to amarked upregu-
lation of endogenous C/EBPa after 16 hr, while only low
levels of C/EBPb were detected. However, after 24 hr,
C/EBPb protein expression increased while C/EBPa expres-
sion was diminished. A surge of C/EBPa and C/EBPb
expression was observed after 120 hr, indicating crosstalk
between transgenic and endogenous C/EBPs during trans-
differentiation (Figure S2B).
Synergistic collaboration between C/EBP family mem-
bers was previously described as a key element to specify
myeloid differentiation (Akagi et al., 2010). To examine
the contribution of endogenous C/EBPs to lympho-
myeloid transdifferentiation, we treated B cells generated
from a homozygous Cebpaf/f;Cebpbf/f mouse with cell-
permeable Cre-recombinase to generate double-knockout
derivatives (Figure S2C). Verified CebpaD/D;CebpbD/D dou-
ble-knockout B cell clones were designated as ‘‘B-DKO’’
(Figure S2D).
B-DKO cells or isogenic controls (not treated with Cre-re-
combinase) were infected with the G/M-transdifferentia-
tion proficient retroviral constructs that co-expressed
C/EBPb and GFP (MIG) or C/EBPε and BFP (MIB) (Figures
3A and 3B). GFP+BFP+ gated cell populations, indicative
of C/EBPb and C/EBPε expression, were analyzed (Fig-
ure 3C). Deletion of endogenous Cebpa and Cebpb strongly
impaired transdifferentiation induced by C/EBPε or
C/EBPb after 4 days, in comparison with isogenic controls
(Figures 3C and S2E). Transdifferentiation efficacy in
C/EBPε-expressing B-DKO cells could be partially rescued
by retroviral co-expression of C/EBPb. These data suggest
synergistic effects between endogenous and exogenous
C/EBPs during transdifferentiation (Figures 3C and S2E).
Comparison of gene expression in C/EBPε-transduced
wild-type or B-DKO cells revealed genes that were depen-
dent on endogenous Cebpa and Cebpb (Figure S2F and
Table S1). The list of refractory genes included Csf1r,
Fcgr1, Itgam (CD11b), and the transcription factor Gfi1,
known to promote granulocyte differentiation. These
genes represent important myeloid cell factors, and failure
of induction may explain the impaired transdifferentia-
tion (Figures 3C and S2E). In addition, Pax5 or Pou2f2
(Oct-2) were refractory to downregulation, which could
contribute to the persistence of the B cell phenotype (Fig-
ure S2G and Table S1).Stem Cell Reports j Vol. 8 j 1–14 j February 14, 2017 3
(legend on next page)
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affected by deletion of endogenous Cebpa and Cebpb, we
analyzed C/EBPε-transdifferentiated GFP+CD11b+ cells for
Ly-6G or CD115 surface marker expression after 7 days of
culture. Comparison of transdifferentiated B-DKO and
control cells did not reveal differences in the frequency of
Ly-6G+ versus CD115+ cells in the CD11b+-gated cell popu-
lation (Figure 3D), suggesting that the continuously ex-
pressed transgene product but not endogenous Cebpa and
Cebpb predominantly affected myeloid cell lineage choice.
C/EBP Dosage and Granulocyte-Macrophage Lineage
Choice
Transcription factor dosage is an important determinant in
hematopoietic lineage choice (Dahl et al., 2003; DeKoter
et al., 2007; DeKoter and Singh, 2000; Di Tullio and Graf,
2012; Ma et al., 2014; Rosenbauer et al., 2004; Simmons
et al., 2012). We therefore examined how the level of
C/EBP transgene expression would alter lympho-myeloid
cell fate. As shown in Figures S3A and S3B, GFP intensity
directly correlated with retroviral C/EBP protein expression
and enabled us to examine transcription factor dosage ef-
fects on lympho-myeloid transdifferentiation. Based on
increasing GFP intensity, C/EBPb-transduced B cells were
divided into six fractions, GFP1–6 (Figure 4A). Macrophage
and granulocyte surface marker analysis of the CD11b+
cells revealed a bipartite profile when all GFP+ cells were
included in the analysis (as in Figure 1C). As shown in Fig-
ures 4B and 4C, the distribution of CD11b+Ly-6G+ versus
CD11b+CD115+ shifted according to the GFP intensity.
GFPdim fractions were preferentially CD11b+CD115/+
and Ly-6G. The CD11b+Ly-6G+ cell population expanded
with increasing GFP intensity, while the CD11b+CD115+
cell fraction diminished. The fraction with the highest
GFP intensity (GFP6) consisted mostly of CD11b+Ly-6G+
cells (Figures 4B and 4C). Cytospin preparations of GFPdim-
and GFPhigh-sorted cells showed that the GFPdim fraction
consisted of large cells, characteristic of monocyte/macro-
phages, while the GFPhigh fraction contained cells with in-
dented and segmented nuclei—typical features of mature
granulocytes (Figure 4D). Finally, B cells transduced with
C/EBPε were separated by flow cytometry according to
their GFP intensity 24 hr post infection. Six days later,
cell-surface marker expression analysis indicated that the
GFPhigh cells were enriched for Ly-6G+ versus CD115+ cells
when compared with the GFP+ culture. These data indicate
a prospective cell-type outcome according to the initialFigure 2. Transdifferentiation Core Gene Signatures of B Cells In
Quantification of mRNA from GFP+-sorted B cells 24 hr after transducti
downregulated genes, compared with empty vector (MIG) control. O
regulated genes. Key myeloid (in C) and lymphoid (in D) genes are sh
transduced B cells is shown. See also Table S1.C/EBP dosage (Figure 4E). To further exclude artifacts pro-
duced by the bicistronic C/EBP-IRES-EGFPMIG constructs,
we examined the dosage effect using retroviral vectors with
direct C/EBPε-GFP fusion. As shown in Figure S3C, higher
GFP intensity correlated with the G/M surface marker pro-
file. Taken together, these findings show that the dosage of
C/EBPb or C/EBPε transcription factors determines granu-
locyte versus macrophage cell-fate outcome during lym-
pho-myeloid transdifferentiation.
Long-Term Proliferating C/EBPb-Lympho-Myeloid
Progeny Display a GMP-like State and Spontaneously
Differentiate into Granulocytes and Macrophages
To assess the proliferation and lineage-forming capacity of
C/EBPb-transdifferentiated B cells, we aimed to establish a
stably converted B cell line. After the removal of b-mercap-
toethanol, an essential culture supplement for B cell
maintenance, all B cells perished within a few days in
C/EBPb-transduced and empty vector-transduced cells. In
contrast to the controls, however, proliferating GFP+ cells
emerged from C/EBPb-transduced B cells within 2 weeks
after infection. Comparison of surface marker expression
after 8 days and 6 weeks of cell culture showed that the
long-term proliferating cells maintained both macrophage
and granulocyte differentiation potential (Figures 5A and
5C). Cytospin preparations from CD11b+Ly-6G+ and
CD11b+CD115+ sorted cells resembled typical granulocytes
and macrophages, respectively (Figures 5B and 5D). Geno-
typing of rearranged immunoglobulin heavy chain (IgH)
locus of C/EBPb-transduced cells ruled out the possibility
of a contamination with myeloid remnants from initiating
cultures (Figure 5E). Immunoblot analysis showed that
transgenic C/EBPb protein is present and that endogenous
C/EBPb protein isoforms are also upregulated in transdiffer-
entiated cells (Figure 5F). In addition, C/EBPb-transduced
cells grew in a semi-adherent fashion and showed irregular
morphological features typical of myeloid progenitor cells,
in contrast to round, refractile B cells. Upon treatment with
recombinant granulocyte-macrophage colony-stimulating
factor (GM-CSF) the proliferation rate decreased and cells
became adherent, large, and motile, resembling activated
macrophages and suggesting that the transdifferentiated
cells respond tomyeloid signaling pathway activation (Fig-
ures S4A and S4B).
The G/M bilineage phenotype of the transdifferentiated
cells was maintained during more than 6 months
of continuous cell culture. Nevertheless, C/EBPb mayduced with C/EBP Family Members
on with individual C/EBPs. Venn diagram of (A) upregulated and (B)
verlapping core signatures of (C) 22 upregulated or (D) 12 down-
own in bold. The fold change (FC) relative to empty vector (MIG)-
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Figure 3. Endogenous Cebpa and Cebpb Promote Transdifferentiation but Do Not Affect Lineage Outcome
(A) pMSCV-based vectors for the expression of C/EBPb linked to EGFP marker or C/EBPε linked to BFP. Empty vectors (MIG/MIB) were used
as controls.
(legend continued on next page)
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Figure 4. C/EBPb Transgene Dosage Affects Macrophage versus Granulocyte Lineage Outcome
(A) Data binning of C/EBPb-transduced B cells according to GFP intensity (GFP1–6).
(B) Flow cytometric analysis of GFP1–6 bins (CD11b + gated) 6 days after transduction.
(C) Quantification from five independent experiments. Data are presented as mean ± SEM.
(D) Cytospin preparation and May-Gru¨nwald staining of GFPdim- and GFPhigh-sorted C/EBPb-transduced B cells at day 7. Arrows indicate
macrophage and arrowheads granulocyte-like cells.
(E) B cells were transduced with C/EBPε, sorted after 24 hr as GFP+ or GFPhigh, and recultured. Flow cytometric analysis of granulocyte (Ly-
6G+) versus macrophage (CD115+) markers in GFP+CD11b+-gated populations 6 days post sorting.
See also Figure S3.
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progenitors either directly or through a common GMP cell
type. To distinguish between these possibilities, we seeded
4,500 of the stably transdifferentiated cells into semi-solid
medium to derive colonies from single cells. Approxi-(B) CebpaD/D;CebpbD/D or isogenic control B cells (Cebpaf/f;Cebpbf/f)
(C) The GFP+BFP fraction (top panels), GFPBFP+ fraction (middle
analyzed for myeloid (CD11b) and B cell (CD19) markers by flow cyto
(D) CebpaD/D;CebpbD/D B cells and isogenic controls were transduced w
analysis of granulocyte (Ly-6G+) and macrophage (CD115+) cell fracti
See also Figure S2.mately 40–70 colonies were obtained in a single experi-
ment. Individual GFP+ colonies were inspected from day
6 to day 18 and displayed a compact core and a periphery
of larger motile, oval cells, reminiscent of colony-forming
unit GM colonies (Figure 5G). Two colonies were isolatedwere transduced with combinations of the vectors shown in (A).
panels), and GFP+BFP+ fraction (bottom panels) were individually
metry after 4 days.
ith C/EBPε, GFP+-sorted after 24 hr, and recultured. Flow cytometric
ons in GFP+CD11b+-gated populations 7 days after transduction.
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6G+ and CD115+ phenotype indicative of GMP-like poten-
tial (Figure 5H, result for one clone is shown). Subsequent
recloning of one of the isolates in semi-solid medium re-
sulted in stably growing secondary subclones (cloning effi-
ciency between 4% and 6%) and persistence of the
GMP-like phenotype of all 17 subclones examined, as
shown in Figure S5.
We conclude that C/EBPb-induced lympho-myeloid con-
version confers a selective advantage by abrogating the
dependence on B cell survival conditions. These C/EBPb-con-
verted cells acquire cytokine-independent long-term prolifer-
ation capacity and a robust GMP-like potential.DISCUSSION
Transcription factor-mediated conversion of one cell type
into another is an important avenue by which we can
advance our understanding of instructive mechanisms of
cellular lineage commitment and differentiation. The pri-
mary B cells immortalized by v-Abl provide an experi-
mental system to combine B cell mouse genetics and
ectopic gene expression for the exploration of progenitor
biology, lympho-myeloid lineage plasticity, maintenance
of cell identity, and regulatory mechanisms of myeloid
lineage commitment.
Experimental transdifferentiation of B cells by ectopic
expression of conditional C/EBPa has shed light on the
molecular dynamics of the conversion of lymphoid cells
into inflammatory macrophages (Bussmann et al., 2009;
Di Tullio et al., 2011; Krijger et al., 2016; Laiosa et al.,
2006; Rodriguez-Ubreva et al., 2012, 2014; van Oevelen
et al., 2015; Xie et al., 2004). However, lympho-myeloid
transdifferentiationmay not be restricted to activatedmac-
rophages butmay yield othermyeloid cell types depending
on the C/EBP structure and post-translational modification
pattern (Stoilova et al., 2013). Here, we assessed the lym-Figure 5. Long-Term Proliferating GMP-like Cells Derived from C/
(A) Cebpaf/f;Cebpbf/f B cells transduced with C/EBPb or vector control (
myeloid surface markers was performed after 6 days. Gating strategy
(B) May-Gru¨nwald staining of macrophage (CD11b+CD115+) or granul
(A) and GFP+-purified empty vector (MIG)-transduced cells as control
(C and D) Flow cytometry analysis (C) and May-Gru¨nwald staining (D)
6 weeks after removal of b-mercaptoethanol.
(E) Analysis of immunoglobulin heavy chain (IgH) rearrangement o
Monocytic Raw264.7 (Mph) cells served as a control for IgH germ lin
(F) Immunoblot analysis of C/EBPb from protein lysates of long-term
C/EBP isoforms; asterisk indicates the size of transgene.
(G) Colony formation from single cells. Phase contrast (top) and fluore
B cell colony. Clonogenic growth is shown at days 6 and 18. Magnific
(H) Flow cytometric characterization of the recultured cell clone deri
See also Figure S5.pho-myeloid transdifferentiation potential of C/EBP a, b,
d, and ε in primary v-Abl-immortalized B cells. Our data
show that v-Abl B cells represent a robust in vitro system
for experimental cell lineage switch and may also be used
for targetedmurine genetics and in vitro genetic manipula-
tion at the B cell stage.
Lineage conversion could be achieved using any of the
four C/EBP members, revealing a common gene signature,
and their common potential to extinguish B cell identity
and induce the myeloid cell fate. C/EBPb and C/EBPε
induced granulocytic differentiation in addition to mono-
cytic transdifferentiation. Granulopoietic capacity of
C/EBPb has previously been documented in emergency
granulopoiesis (Hirai et al., 2006) and by restoring Cebpa
deficiency (Jones et al., 2002). The lack of granulopoietic
transdifferentiation potential of C/EBPa was surprising
and has been discussed previously (Xie et al., 2004),
because C/EBPa induced granulocyte differentiation in a
myeloid progenitor cell line (Radomska et al., 1998; Suh
et al., 2006). Although we do not know why C/EBPa and
C/EBPd fail to induce granulocyte formation, the strong
proliferation arrest elicited by C/EBPa could account for
the failure of granulocytic conversion. On the other
hand, our data may also raise the possibility that some of
the functions of C/EBPa reported in established progenitor
cell lines may depend on the activation of endogenous
C/EBPb. Nevertheless, the v-Abl B cell system could be use-
ful to resolve quantitative and qualitative C/EBP functions
and help uncover mechanisms of lineage specification,
e.g., by C/EBP domain-swap experiments and mutational
analysis.
Our findings support the concept that subtle variations
in transcription factor levels have an impact on hemato-
poietic cell lineage decisions. In addition to transcription
factor dosage, specificity and functional redundancy play
major roles; high levels of C/EBPb or C/EBPε consistently
increased the granulocyte over macrophage ratio. The
exact interplay between C/EBP quantity and qualitativeEBPb-Transduced B Cells
MIG), sorted after 24 hr, and recultured. Flow cytometric analysis of
is indicated by arrows.
ocyte (CD11b+Ly-6G+) marker-sorted C/EBPb-transduced cells from
.
according to (A) and (B) of non-purified C/EBPb-transduced cells
f long-term C/EBPb-transduced cells or MIG-transduced controls.
e (Gl) configuration.
C/EBPb- or empty vector (MIG)-transduced B cells. Arrows indicate
scent signal (bottom) micrographs of a C/EBPb-transdifferentiated
ation of inset area focuses on the border of the colony.
ved from (G) using myeloid markers.
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graded PU.1 expression that has an impact on lympho-
myeloid specification by occupancy of low-affinity bind-
ing sites only at high transcription factor concentrations
(DeKoter and Singh, 2000; Pham et al., 2013). Relative
expression levels of PU.1 and C/EBPa are also key determi-
nants in granulocyte versus macrophage specification.
Higher PU.1 levels promote macrophage differentiation,
while higher C/EBPa levels lead to granulopoiesis (Dahl
et al., 2003; Ma et al., 2014). Therefore, less accessible
‘‘granulocytic genes’’ may require higher C/EBP concentra-
tions in addition to other features of C/EBPb and C/EBPε
proteins.
Activation of endogenous C/EBP genes and impaired
lineage conversion after their removal suggests that
autoregulatory loops are involved in the kinetics of lineage
conversion (Bussmann et al., 2009; Lu et al., 2009). How-
ever, deletion of endogenous C/EBPa and C/EBPb appears
to affect the conversion efficiency but not the lineage
outcome, suggesting a dominant and distinguished quali-
tative role for the constitutively expressed C/EBP
transgene.
Leukemiawith indifferent or promiscuous lineage associ-
ation is frequently resistant to standard chemotherapy and
may show changed lineages during relapse (Dorantes-
Acosta and Pelayo, 2012; Golemovic et al., 2006; Matutes
et al., 1997). Inter-myeloid and lympho-myeloid lineage
ambiguity therefore emerges as an important pathological
entity (Greaves et al., 1986; Smith et al., 1983). It is there-
fore conceivable that switching lineages reflect an epige-
netic selection process in leukemogenesis associated with
gain-of-function survival and proliferation capacity
(Greaves et al., 1986; Janz et al., 2006; Regalo and Leutz,
2013). Our experimental data provide direct evidence
that enhancing the selective pressure on B cells by removal
of b-mercaptoethanol strongly promotes C/EBPb-induced
lympho-myeloid converts that remained immortalized
and highly proliferative. We therefore conclude that
cancerous B cells may escape from hostile conditions by
lineage conversion through C/EBPb activation. Further-
more, B cells could profit from lineage-foreign survival sig-
nals by aberrant expression of growth factor receptors, such
as CSF1-R, a target gene of C/EBPb (Lamprecht et al., 2010).
Various C/EBP translocations have been associated with B
cell-derived leukemia, implying their cancer-supporting
function. However, the role played by transdifferentiation
remains unknown (Akasaka et al., 2007; Chapiro et al.,
2006; Slamova et al., 2013;Wiemels et al., 2015). Strikingly,
DNA demethylation and upregulation of C/EBPa was sus-
pected to be involved in lineage switching during leukemia
progression (Slamova et al., 2013). In addition to pre-B cell
lymphoma, v-Abl retroviral infection of murine bone
marrow cells also evoked a chronic myeloid leukemia-like10 Stem Cell Reports j Vol. 8 j 1–14 j February 14, 2017disease that involved immunoglobulin rearrangements
(Kelliher et al., 1990).
In a recent study, pulsed C/EBPa expression was shown
to induce a GMP-like state according to gene expression
and chromatin accessibility data. However, during pro-
longed exposure only a macrophage fate was consolidated
(Di Stefano et al., 2016). Remarkably, the stable C/EBPb B
cell converts reported here resembled self-renewing bipo-
tential GMP progenitors that were responsive to GM-CSF
but not dependent on cytokine signaling, and stably
retained G/M differentiation potential. In the absence of
cytokines, expression of macrophage- and granulocyte-
specific markers emerged in a mutually exclusive fashion.
These data suggest the involvement of C/EBPb in mainte-
nance, commitment, or both at the GMP stage.
The cytokine-independent, self-renewing, spontane-
ously differentiating GMP-like cells present a valuable
experimental tool for the study of determinants of granulo-
cyte versus macrophage specification by genetic manipula-
tion and screening approaches. In addition, maintenance
of the transdifferentiation capacity of the v-Abl B cells es-
tablishes a sound basis for using targeted genetic mouse
models to examine signaling pathways and other instruc-
tive cues of cell specification. The fact that v-Abl B cells
are amenable to DNA transfection permits experimental
alteration at the B cell stage, such as stable transfection,
gene deletion, or chromosomal engineering, and is an
important technical advance in overcoming the hurdle of
difficult genetic manipulation of myelomonocytic cells.
In summary, we present a robust in vitro lympho-
myeloid transdifferentiation system to study determinants
of lineage promiscuity, GMP progenitor biology, and
macrophage versus granulocyte cell-fate decisions. In addi-
tion, our findings lend experimental evidence to lympho-
myeloid transdifferentiation processes as a trait of lineage
ambiguity in leukemia progression.EXPERIMENTAL PROCEDURES
Expression Constructs
C/EBP genes were inserted into pMSCV-IRES-EGFP (MIG) or
pMSCV-IRES-BFP (MIB) retroviral vectors using XhoI/EcoRI restric-
tion sites. C/EBPs lacking stop codons were cloned in-frame with
the EGFP open reading frame and inserted into pMSCV for
C/EBP-GFP fusion construct. Expression vectors encoding
C/EBPa p42 isoform and C/EBPb LAP* isoform were described pre-
viously (Stoilova et al., 2013). Murine C/EBPd was isolated from
pMEX-mC/EBPd (a gift fromDr. E Sterneck). Codon-optimized hu-
man C/EBPε p32 isoform was commercially synthesized (MWG-
Biotech) and subcloned from pEX-A2 intoMIG orMIB using EcoRI
sites flanking C/EBPε. The v-Abl-expressing pMSCV vector was a
gift fromDr. FMelchers (Ohnishi andMelchers, 2003). For produc-
tion of infectious supernatants the retroviral packaging cell line
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72 hr after transfection.
Generation of v-Abl-Transformed B Cells
Bone marrow cells were isolated from the femur and tibia of 8- to
9-week-old Cebpaf/f-crossed (Zhang et al., 2004) and Cebpbf/f-
crossed (Sterneck et al., 2006) Cebpaf/f;Cebpbf/f mice and
C57BL/6J wild-type controls. These mice were maintained and
handled in compliance with protocols approved by the institu-
tional Animal Care and Use Committee. After erythrolysis, bone
marrow cells were transduced with v-Abl-expressing retroviral su-
pernatants and 8 mg/mL hexadimethrine bromide in complete
DMEM (10% fetal calf serum (FCS), 10 mM HEPES, and peni-
cillin/streptomycin (Gibco)) supplemented with 50 mM b-mercap-
toethanol. Bone marrow cells were washed on the following day
and medium was changed every other day. A stable cell line with
a pre-B cell-like phenotype (CD19+, c-kit, CD25+, IgM) emerged
after 4 weeks of culture. For loxP site recombination, 53 105 B cells
were washed three times in serum-free DMEM and incubated with
purified TAT-Cre protein (50 mg/mL; a gift from Dr. K Rajewsky) in
serum-free DMEM at 37C for 45 min (Peitz et al., 2002). The cells
were then washed and cultured for 24 hr and seeded subsequently
as single-cell clones (by fluorescence-activated cell sorting (FACS))
into 96-well plates. Deletion of the Cebpa and Cebpb genes was
checked by PCR to identify double-knockout clones. Primer se-
quences used are shown in Table S2.
Cell Lines
The monocytic/macrophage Raw264.7 cell line was cultured in
complete DMEM. The fetal liver-derived pre-B cell line HAFTL1
was cultured in complete RPMI-1640 (10% FCS, 10 mM HEPES,
penicillin/streptomycin (Gibco)) supplementedwith 50 mM b-mer-
captoethanol (Pierce and Aaronson, 1982). The HAFTL1-derived
C10 clone (a gift from Dr. T Graf) containing a C/EBPa-ER_IR-
ES_GFP transgene was cultured in complete phenol red-free
RPMI-1640 (10% charcoal-stripped FCS (HyClone), 10mMHEPES,
penicillin/streptomycin (Gibco)) supplementedwith 50 mM b-mer-
captoethanol (Bussmann et al., 2009). Transdifferentiation of C10
cells was induced with 200 nM hydroxytamoxifen (Sigma). 293T-
derived Plat-E line (Cell Biolabs) was used for packaging.
Retroviral Transduction
v-Abl-generated stable B cells or HAFTL1 cells (2 3 105/12-well or
13 106/6-well) were mixed with freshly prepared retroviral super-
natants (1/3 of total volume) in complete medium supplemented
with 8 mg/mL hexadimethrine bromide and 50 mM b-mercaptoe-
thanol. Cells were centrifuged at 1,000 rpm without brakes for
10 min at room temperature and incubated overnight. Infected
cells were washed and processed for flow cytometry or replated
in 6-well plates (BD Falcon). For the generation of the long-term
proliferating transdifferentiated cells, b-mercaptoethanol supple-
mentation was omitted after 24 hr. Half of the medium was
changed every other day.
Flow Cytometry
For flow cytometry or cell sorting, cells were transferred to 15-mL
tubes and washed in cold buffer (2% FCS, 2 mM EDTA in PBS).Before antibody labeling, cells were incubated with Fc-Block
(1:200, anti-CD16/32 antibody; 2.4G2, BD Pharmingen) for
10 min at 4C and washed. Cells were stained in buffer with
(1:100) fluorescently labeled antibodies against CD11b (clone
M1/70, BD Pharmingen), CD11c (clone N418, Biolegend),
CD115 (cloneAFS98, eBioscience), CD19 (clone 1D3, BD Pharmin-
gen), and Ly-6G (1A8, Biolegend) for 30 min at 4C in the dark.
7-AAD (BD Pharmingen) was added before measurement to
exclude dead cells. Analysis was performed on LSRFortessa and
sorting on FACSAria II or III (BD Pharmingen). Unstained, empty
vector-transduced cells or fluorescence-minus-one staining setups
served as controls.
PCR
Total RNA was prepared using TriPure (Roche) following the man-
ufacturer’s instructions. DNA contamination was removed by
DNase I treatment (Roche). For standard cDNA synthesis the Rever-
tAid First Strand Synthesis Kit (Thermo Scientific) was used. Ten
nanograms of cDNA was applied to PCR according to the Mango-
Taq kit protocol (Bioline). PCR reaction was subjected to 94C for
3 min and 27 cycles of 94C for 30 s, 56C for 30 s, 72C for 30 s,
and a final extension step at 72C for 5 min on a Mastercycler
Pro (Eppendorf). For detection of DH-JH IgH rearrangements,
DNAwas prepared as described by Truett et al. (2000) and subjected
to PCR conditions as reported by Ehlich et al. (1994), using the
combination of primers DQ52 FW1, DFS FW2, and JH4A RV.Cebpa
and Cebpb genotypes were assessed using ‘‘-flox’’ or ‘‘-D’’ primer
pairs, respectively.
Immunoblotting
Total protein lysates were prepared by incubation of snap-frozen
cell pellets with lysis buffer (50 mM Tris-HCl (pH 7.4), 150 mM
NaCl, 1% Nonidet P-40, 1 mM EDTA, 10% glycerol, and protein-
ase inhibitor cocktail [Roche] in H2O) for 30 min on ice. After
centrifugation protein concentration was measured in superna-
tants using Pierce Reagent (Thermo Scientific). Protein lysates
were subjected to electrophoresis and transferred to a nitrocellu-
lose membrane on the Trans-Blot Turbo System (Bio-Rad).
Specific protein signals were detected by incubation with anti-
bodies against C/EBPa (14AA, Santa Cruz Biotechnology),
C/EBPb (C-19, Santa Cruz), C/EBPd (C-22, Santa Cruz), C/EBPε
(C-22, Santa Cruz), GFP (7.1/13.1, Roche), and ACTB (AC-15,
Sigma).
NanoString Analysis
Total RNA from freshly FACS-enriched cells or cell cultureswas pre-
pared and quality checked on a 2100 Bioanalyzer (Agilent Technol-
ogies). Detection of mouse protein-coding transcripts was per-
formed using a predefined panel (GXA-MIM1-12, nCounter),
containing 547 probes against immunology-related mRNAs and
14 probes against housekeeping genes (G6pdx, Hprt, Gapdh,
Alas1, Oaz1, Sdha, Rpl19, Eef1g, Tbp, Ppia, Polr2a, Gusb, Tubb5,
and Polr1b) for normalization. Primary data were processed using
default settings of the nSolver software. Genes were defined as ‘‘up-
regulated’’ or ‘‘downregulated’’ if normalized expression values
were increased or decreased at least 2-fold compared with empty
vector-transduced controls.Stem Cell Reports j Vol. 8 j 1–14 j February 14, 2017 11
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Processed data were visualized using GraphPad Prism software
(Version 5.0a). Error bars represent the SEM. Hypothesis testing
was performed from at least three independent experiments using
the t-test function (two-tailed) in Rstudio (R version 3.2.1, R Foun-
dation). p Values of <0.05 were defined as significant and p < 0.01
highly significant.
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Figure S1: Lympho-myeloid conversion potential of C/EBP family members, 
Related to Figure 1 
(A) Immunoblot analysis of C/EBP family members of total protein lysates from Plat-E 
cells 72 h after transduction with C/EBP-MIG constructs. Untransduced cells served 
as control and ACTB as housekeeping gene. (B) Flow cytrometric analysis of B cells 
transduced with individual C/EBPs focusing on macrophage (CD11b+CD115+), den-
dritic (CD11b+CD11c+) and granulocytic (CD11b+Ly-6G+) markers 4 days after trans-
duction. (C) Semi-quantitative RT-PCR analysis of C/EBP expression in murine pri-
mary FACS-purified B cells (CD19+), granulocytes (CD11b+Ly-6G+) and 
macrophages (CD11b+CD115+). Gapdh served as housekeeping gene. (D) Flow cy-
tometric analysis of C/EBP-transduced GFP+-gated HAFTL1 cells 4 days after induc-
tion. 
 
Figure S2:  The role of endogenous Cebpa and Cebpb on transdifferentiation, 
Related to Figure 3 
(A) Semi-quantitative RT-PCR expression analysis of endogenous C/EBP family 
members in C10 cells treated with OHT for 4 days and non-induced controls 
(Bussmann et al. 2009). RNA from total bone marrow or monocytic Raw264.7 cells 
served as controls. Gapdh was used as housekeeping gene. (B) Expression kinetics 
of endogenous C/EBPα, and β protein in C/EBPε-transduced B cells based on im-
munoblot analysis. (C) Workflow for the generation of Cebpa and Cebpb double 
knockout v-Abl immortalized B cells and isogenic controls derived from a mouse with 
homozygous floxed Cebpa and Cebpb alleles. Deletion of Cebpa and Cebpb by in-
cubating cells with recombinant Cre-recombinase. (D) Cebpa and Cebpb genotypes 
of established Cre-incubated cell clones was assessed by PCR. Pools of Cre-treated 
and untreated cells served as controls. Clone 4 was selected for further experiments. 
(E) Quantification of transdifferentiated cells (CD11b+, related to Figure 3C) from four 
independent experiments. ±SEM, **p<0.01. (F) Nanostring analysis showing upregu-
lated genes 24 h after C/EBPε transduction in GFP+-sorted cells compared to control 
B cells (MIG-transduced). Genes that were not upregulated in CebpaΔ/Δ;CebpbΔ/Δ 
cells are marked in red. (G) Downregulated genes in GFP+ FACS-purified control 
cells transduced for one day with C/EBPε compared to empty vector. Genes refracto-
ry to down-regulation in CebpaΔ/Δ;CebpbΔ/Δ cells are marked in red. See also Table 
S1. 
 
Figure S3: Effect of C/EBPε dosage on transdifferentiated cell type outcome, 
Related to Figure 4 
(A) Sorting scheme of GFP+ Plat-E cells transduced with empty vector control (MIG) 
or C/EBPε-MIG for 72 h. (B) Immunoblot detection of C/EBPε, GFP and ACTB in pro-
tein lysates of 1 × 106 FACS-purified cells from GFP-fractions in (A). Two exposure 
times (short and long) are shown. (C) B cell were transduced with pMSCV-based 
vectors either containing bi-cistronic C/EBPε-IRES-EGFP (top panels) or C/EBPε-
EGFP fusion (bottom panels) transgenes. Transduced cells were classified according 
to GFP intensity and analysed for CD11b+Ly-6G+ and CD11b+CD115+ fractions.  
 
Figure S4: Myeloid signalling-response of transdifferentiated bi-potential cells, 
Related to Figure 5 
(A) Bright field images of long-term C/EBPβ-transduced cells, untreated or treated 
with 10 ng/ml GM-CSF for 24 h. Empty vector (MIG) transduced B cells served as 
control. (B) Subsequent cytospin preparations and May-Grünwald-staining after 16 
days of culture. 
 Figure S5: Persistence of the GMP-like phenotype after serial subcloning, 
Related to Figure 5 
Analysis of 17 subclones derived from a GMP-like parental clone presented in Figure 
5G,H. Flow cytometric analysis of CD115 versus Ly-6G in the GFP+CD11b+-gated 
population indicates persistence of the GMP-like potential. 
 
Supplemental Tables 
Table S1: Gene expression signature in C/EBP-transduced B cells, 
Related to Figure 2, 3 
Nanostring analysis (gene set GXA-MIM) of GFP+ B cells (Cebpaf/f;Cebpbf/f) trans-
duced with individual C/EBPs for 24 h. C/EBPε-infected CebpaΔ/Δ;CebpbΔ/Δ B cells 
(B-DKO) were included for comparison. MIG-transduced cells served as control. 












 Table S2: List of  primer sequences, 
Related to Experimental Procedures, Figure 4, Figure S1, S2 
Oligonucleotide Sequence 5'-3' 
Cebpa FW GCCAGTTGGGGCACTGGGTG 
Cebpa RV CCGCGGCTCCACCTCGTAGA 
Cebpb FW GCGTTCATGCACCGCCTGCT 
Cebpb RV TAGGCCAGGCAGTCGGGCTC 
Cebpd FW AGAACCCGCGGCCTTCTAC 
Cebpd RV ATGTAGGCGCTGAAGTCGAT 
Cebpe FW CACACTGCGGGCAGACAG 
Cebpe RV GTGCCTTGAGAAGGGGACT 
Gapdh FW AATGTGTCCGTCGTGGATCTGA 
Gapdh RV GATGCCTGCTTCACCACCTTCT 
Cebpa flox FW TGGCCTGGAGACGCAATGA 
Cebpa flow RV CGCAGAGATTGTGCGTCTTT 
Cebpa Δ FW GCCTGGTAAGCCTAGCAATCCT 
Cebpa Δ RV TGGAAACTTGGGTTGGGTGT 
Cebpb flox/Δ FW GAGCCACCGCGTCCTCCAGC 
Cebpb flox RV GGTCGGTGCGCGTCATTGCC 
Cebpb Δ RV AGCAGAGCTGCCCCGGCAAA 
DQ52 FW1 ACGTCGACTTTTGYAAGGGATCTACTACTGT 
DFS FW2 ACGTCGACGCGGACGACCACAGTGCAACTG 
JH4A RV GGGTCTAGACTCTCAGCCGGCTCCCTCAGGG 
 
